Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

A terminated Phase 1 study evaluating safety, tolerability, and pharmacokinetics of escalating doses of AGS67E as monotherapy in adults with acute myeloid leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AGS67E

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED